GlassScriptPhysician profile
Glenn C Vitale
NPI 1730189556
$1,071.73
in general payments reported to CMS, 2019-2025
11 companies · $39.84 in 2025
The $39.84 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $117 · 2021: $134 · 2022: $79.14 · 2023: $17.61 · 2024: $260 · 2025: $39.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.97 |
| Education | $109.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $180.13 | 2019-2020 | |
| Celularity INC. | $154.00 | 2019 | |
| Bioventus LLC | $131.90 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Djo, LLC | $126.61 | 2023-2024 | Dr Comfort |
| Medtronic, INC. | $124.26 | 2021-2022 | |
| Endo USA, INC. | $119.57 | 2024 | |
| Organogenesis INC. | $115.51 | 2019 | |
| Paratek Pharmaceuticals, INC. | $53.41 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $32.63 | 2019 | |
| Horizon Therapeutics Plc | $20.13 | 2021 | |
| Triad Life Sciences INC. | $13.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Vitale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.